Dihexyl phthalate


Curated chemical-gene interactions from CTD
Entrez gene IDGene symbolInteraction typeReference
10682 EBP Decreases expression PMID:33983380
10858 CYP46A1 Decreases expression PMID:33983380
10891 PPARGC1A Decreases expression PMID:32693021
111785 HSD3B Decreases expression PMID:22112501
13121 CYP51 Decreases expression PMID:33983380
1375 CPT1B Decreases expression PMID:33043605
15494 HSD3B3 Decreases expression PMID:32693021; PMID:32693021; PMID:33983380
1583 CYP11A1 Decreases expression PMID:22112501; PMID:23754470; PMID:26934186; PMID:33983380; PMID:26934186
1584 CYP11B1 Decreases expression PMID:22112501; PMID:33983380
1585 CYP11B2 Decreases expression PMID:33983380
1586 CYP17A1 Decreases expression PMID:22112501; PMID:23754470; PMID:26934186; PMID:33983380; PMID:26934186
1717 DHCR7 Decreases expression PMID:33983380
190 NR0B1 Decreases expression PMID:33983380
2099 ESR1 Increases activity PMID:15840436
2099 ESR1 Increases expression PMID:22112501
2100 ESR2 Decreases activity PMID:15840436
217 ALDH2 Decreases expression PMID:33983380
2180 ACSL1 Decreases expression PMID:33043605
2194 FASN Decreases expression PMID:33043605
2224 FDPS Decreases expression PMID:33983380
23411 SIRT1 Decreases expression PMID:32693021
3156 HMGCR Decreases expression PMID:26934186; PMID:33983380
3157 HMGCS1 Decreases expression PMID:26934186; PMID:33983380
3283 HSD3B1 Decreases expression PMID:26934186; PMID:32693021; PMID:32693021
3290 HSD11B1 Decreases expression PMID:32693021
3293 HSD17B3 Increases expression PMID:26934186
33 ACADL Decreases expression PMID:33043605
34 ACADM Decreases expression PMID:33043605
3553 IL1B Increases expression PMID:33043605
3623 INHA Decreases expression PMID:22112501; PMID:33983380
3638 INSIG1 Decreases expression PMID:33983380
3640 INSL3 Decreases expression PMID:22112501; PMID:33983380
3949 LDLR Decreases expression PMID:33983380
3972 LHB Increases expression PMID:32693021
3973 LHCGR Decreases expression PMID:32693021; PMID:32693021; PMID:33983380
434769 RHOX10 Decreases expression PMID:22112501
4597 MVD Decreases expression PMID:33983380
496902 ELA3B Increases expression PMID:33983380
50814 NSDHL Decreases expression PMID:33983380
50846 DHH Increases expression PMID:32693021
581 BAX Increases expression PMID:33043605
596 BCL2 Decreases expression PMID:33043605
60481 ELOVL5 Decreases expression PMID:33043605
6770 STAR Decreases expression PMID:22112501; PMID:23754470; PMID:26934186; PMID:33983380
689872 IDI2L3 Decreases expression PMID:33983380
7040 TGFB1 Decreases expression PMID:22112501
7108 TM7SF2 Decreases expression PMID:33983380
7124 TNF Increases expression PMID:33043605
7476 WNT7A Decreases expression PMID:22112501; PMID:33983380
836 CASP3 Increases expression PMID:33043605
841 CASP8 Increases expression PMID:33043605
9415 FADS2 Decreases expression PMID:33043605
949 SCARB1 Decreases expression PMID:22112501; PMID:23754470; PMID:26934186; PMID:33983380
9970 NR1I3 Increases activity PMID:28927721

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.